← Leaderboards
Barth Lance Wilsey
University Of California Davis
$1,225,243
Attributed
$1,760,835
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $649.6K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,760,835 · 3
By mechanism
R01$1,632,948 · 2
M01$127,887 · 1
Top collaborators
- Thomas D Marcotte2 shared
Most similar at University Of California Davis
Same institution · by research overlap
- Laura S Van Winkle$14,575,573
- Alan R Buckpitt$10,908,360
- Bill Lee Lasley$5,635,085
- Kate M Scow$2,028,057
- Kent E Pinkerton$25,850,651
Others in their field
Top investigators on “Verbal Learning”
- Jose A Luchsinger · Columbia University Health Sciences$16,805,731
- Linmarie Sikich · University Of North Carolina Chapel Hill$9,736,060
- Raquel E Gur · University Of Pennsylvania$9,627,465
- Sophia Vinogradov · University Of Minnesota$9,527,941
- Jill M Goldstein · Massachusetts General Hospital$9,465,810
- Robert W Buchanan · University Of Maryland Baltimore$7,754,496
Research focus
Verbal LearningTetrahydrocannabinolMemoryPainPsychomotor PerformanceResponseDigit StructureLearningModalityNeuropsychologicalPlacebosAttentionAffectRandomizedBaseAdverse EffectsDouble-Blind MethodIntoxicationBreathingAnalgesicsMoodsCannabinoidsCannabisPain Intensity
Grant awards (5)
A Randomized, Cross-Over Controlled Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain$649,606
R01 · FY2016 · DA · contact PI
A Randomized, Cross-Over Controlled Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain$421,579
R01 · FY2015 · DA · contact PI
The Effect of Vaporized Cannabis on Neuropathic Pain in Spinal Cord Injury$305,474
R01 · FY2012 · DA · contact PI
The Effect of Vaporized Cannabis on Neuropathic Pain in Spinal Cord Injury$256,289
R01 · FY2011 · DA · contact PI
A DOUBLE BLIND, ACTIVE PLACEBO CONTROLLED CROSSOVER TRIAL OF THE ANTINOCICEPT$127,887
M01 · FY2005 · RR